本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

23.69
-2.6700-10.13%
盘后23.690.00000.00%18:21 EDT
成交量:70.94万
成交额:1,714.17万
市值:15.39亿
市盈率:-7.94
高:25.07
开:24.64
低:23.64
收:26.36
数据加载中...
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

重要事件披露

Form 8-K - Current report
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/14

重要事件披露

Form 8-K - Current report
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]